Advanced in Virilizing Ovarian Tumor

Dr. Matei P. Socoteanu

Oncology | Hospital Medicine | Hematology Oncology
Texas Oncology PA
2026 S Jackson St, 
Jacksonville, TX 
 (922.9 mi)
Accepting New Patients
Offers Telehealth
Advanced in Virilizing Ovarian Tumor
Texas Oncology PA
2026 S Jackson St, 
Jacksonville, TX 
 (922.9 mi)
OverviewInsuranceLocationsClinical Research

Overview

Matei Socoteanu is an Oncologist and a Hospital Medicine provider in Jacksonville, Texas. Dr. Socoteanu and is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lung Cancer, and Non-Hodgkin Lymphoma. Dr. Socoteanu is currently accepting new patients.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hospital Medicine
Hematology Oncology
Licenses
Internal Medicine in TN
Hospital Affiliations
Christus Good Shepherd Medical Center
Longview Regional Medical Center
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Blue Cross Blue Shield
  •  Friday Health
  •  Oscar
  •  UnitedHealthcare
  •  Humana

Locations

TEXAS ONCOLOGY PA
2026 S Jackson St, Jacksonville, TX 75766
Other Locations
TEXAS ONCOLOGY PA
1400 N 4th St, Longview, TX 75601
TEXAS ONCOLOGY PA
7848 Gateway Blvd E, El Paso, TX 79915

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
Enrollment Status: Completed
Publish Date: June 11, 2024
Intervention Type: Drug
Study Drugs: Brentuximab, Bendamustine, Dacarbazine, Nivolumab
Study Phase: Phase 2
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
Enrollment Status: Terminated
Publish Date: January 20, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
Enrollment Status: Terminated
Publish Date: September 11, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

2 Total Publications

Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2).
Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 10, 2020
Similar Doctors
Advanced in Virilizing Ovarian Tumor
Dr. Courtney S. Yau
Oncology | Hematology Oncology
Advanced in Virilizing Ovarian Tumor
Dr. Courtney S. Yau
Oncology | Hematology Oncology

Texas Oncology PA

2026 S Jackson St, 
Jacksonville, TX 
903-586-2456
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Courtney Yau is an Oncologist and a Hematologist Oncology provider in Jacksonville, Texas. Dr. Yau and is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Thrombocytopenia, and Multiple Myeloma. Dr. Yau is currently accepting new patients.

Advanced in Virilizing Ovarian Tumor
Dr. Kavita Nirmal
Hematology Oncology | Oncology | Hematology
Advanced in Virilizing Ovarian Tumor
Dr. Kavita Nirmal
Hematology Oncology | Oncology | Hematology

Texas Oncology PA

1400 N 4th St, 
Longview, TX 
 (49.9 mi)
903-757-2122
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kavita Nirmal is a Hematologist Oncology specialist and an Oncologist in Longview, Texas. Dr. Nirmal and is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Familial Colorectal Cancer, Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma. Dr. Nirmal is currently accepting new patients.

Advanced in Virilizing Ovarian Tumor
Dr. Anna M. Priebe
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Advanced in Virilizing Ovarian Tumor
Dr. Anna M. Priebe
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Texas Oncology PA

910 E Houston St, Suite 100, 
Tyler, TX 
 (28.2 mi)
903-579-9800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anna Priebe is a Gynecologic Oncologist and an Oncologist in Tyler, Texas. Dr. Priebe and is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Endometrial Cancer, Ovarian Cancer, and Endometrial Stromal Sarcoma. Dr. Priebe is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile